Image: Positive NewsWhat went right this week: the good news that matters - Positive News
• Researchers are launching a clinical trial to determine if the experimental drug trontinemab can prevent people with high p-tau217 levels from developing dementia. • The study aims to recruit 1,600 participants following previous research showing the drug cleared amyloid plaques, a hallmark of Alzheimer's, in 90% of early-stage patients. • A successful outcome could provide a preventative medical treatment for individuals at high risk of cognitive decline before symptoms appear.
positive.news


